Voices of Biotech
Podcast: Sustainability equals efficiency, says eXmoor
eXmoor Pharma discusses the steps taken to build a more sustainable facility, the importance of its design, and calls for industry to share advice and initiatives.
Provention Bio says the US FDA’s CMC concerns relating to its type 1 diabetes candidate teplizumab are addressable in the short-term.